HER2-Positive Gastric Cancer

被引：0
|
作者：
Haralabos Demetriades
机构：
[1] Aristotle University of Thessaloniki,4th Surgical Department
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Gastric Cancer; Trastuzumab; Gastric Cancer Patient; Adjuvant Setting; HER2 Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：1
相关论文
共 50 条
  • [41] Trastuzumab: A Review of Its Use in HER2-Positive Advanced Gastric Cancer
    Mark Sanford
    Drugs, 2013, 73 : 1605 - 1615
  • [42] LapatinibDevelopment of resistance to metastatic HER2-positive gastric cancer: case report
    Reactions Weekly, 2018, 1697 (1) : 221 - 221
  • [43] Advanced HER2-positive gastric cancer: Current and future targeted therapies
    Pazo Cid, Roberto A.
    Anton, Antonio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 350 - 362
  • [44] Trastuzumab: A Review of Its Use in HER2-Positive Advanced Gastric Cancer
    Sanford, Mark
    DRUGS, 2013, 73 (14) : 1605 - 1615
  • [45] Antitumor activity of multikinase inhibitors in HER2-positive gastric cancer cells
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Namba, Kei
    Torigoe, Hidejiro
    Sato, Hiroki
    Yamamoto, Hiromasa
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Fujiwara, Toshiyoshi
    Toyooka, Shinichi
    CANCER RESEARCH, 2017, 77
  • [46] Trastuzumab-based treatment of HER2-positive metastatic gastric cancer
    Dogan, I.
    Karabulut, S.
    Tastekin, D.
    Paksoy, N.
    Sakar, B.
    Vatansever, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S205 - S205
  • [47] The efficacy and safety of trastuzumab for unresectable advanced HER2-positive gastric cancer
    Matsueda, Katsunori
    Toyokawa, Tatsuya
    Horii, Joichiro
    Fujita, Isao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 95 - 95
  • [48] Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
    Do-Youn Oh
    Kewn-Wook Lee
    Jae Yong Cho
    Won Ki Kang
    Seock-Ah Im
    Jin Won Kim
    Yung-Jue Bang
    Gastric Cancer, 2016, 19 : 1095 - 1103
  • [49] Antitumor activity of afatinib or neratinib in HER2-positive gastric cancer cells
    Yoshioka, Takahiro
    Shien, Kazuhiko
    Takahashi, Yuta
    Kurihara, Eisuke
    Namba, Kei
    Torigoe, Hidejiro
    Sato, Hiroki
    Yamamoto, Hiromasa
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Fujiwara, Toshiyoshi
    Toyooka, Shinichi
    CANCER SCIENCE, 2018, 109 : 738 - 738
  • [50] Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
    Bang, Yung-Jue
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) : 637 - 648
12345